Prestige Consumer Healthcare PBH North American OTC Healthcare — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prestige Consumer Healthcare's north american otc healthcare — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Prestige Consumer Healthcare's north american OTC healthcare — total revenues?
- Prestige Consumer Healthcare (PBH) reported north american OTC healthcare — total revenues of $234.55M in Q1 2026.
- How has Prestige Consumer Healthcare's north american OTC healthcare — total revenues changed year-over-year?
- Prestige Consumer Healthcare's north american OTC healthcare — total revenues decreased by 5.8% year-over-year, from $248.95M to $234.55M.
- What is the long-term trend for Prestige Consumer Healthcare's north american OTC healthcare — total revenues?
- Over 4 years (2022 to 2026), Prestige Consumer Healthcare's north american OTC healthcare — total revenues has grown at a -1.4% compound annual growth rate (CAGR), from $967.88M to $913.58M.
- What does north american OTC healthcare — total revenues mean?
- The total gross income generated by the North American OTC healthcare segment from the sale of over-the-counter products to customers. This is a primary indicator of the segment's market demand, pricing power, and overall scale within the consumer healthcare industry.